CURE’s skin cancer page is an extensive resource of cancer information featuring the latest skin cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on skin cancer.
June 30th 2021
Patients with basal cell or cutaneous squamous cell carcinoma tend to have good outcomes when the disease is caught early. For those in later stages, new treatments bring hope and better prognoses.
June 29th 2021
Anna C. Pavlick, DO, provides an overview of hedgehog inhibitors, a first-line treatment option for patients diagnosed with locally advanced basal cell carcinoma (laBCC).
June 29th 2021
A discussion about multidisciplinary management of locally advanced basal cell carcinoma (laBCC) and how dermatologists and medical oncologists collaborate within the care of a patient.
June 29th 2021
An expert discusses features of a skin lesion that would prompt a skin biopsy in the diagnosis of locally advanced basal cell carcinoma (laBCC).
June 29th 2021
Anna C. Pavlick, D.O., provides an overview of locally advanced basal cell carcinoma (laBCC) that includes the different risk factors and clinical presentations.
June 27th 2021
Learn the differences between sunscreen types and what to look for.
June 26th 2021
View the full CURE Educated Patient Skin Cancer Summit on demand.
June 17th 2021
Even with newer technologies such as mRNA, experts predict it will be a few years before another cancer vaccine is approved.
June 14th 2021
As we all head outdoors to enjoy the warmer weather, The Skin Cancer Foundation would like to remind everyone how to use sunscreen safely and effectively as part of a complete sun protection strategy.
June 8th 2021
More than six years of follow-up data show that Opdivo alone, or in combination with Yervoy, continued to induce long-term survival benefits compared to Yervoy alone in patients with previously untreated advanced skin cancer.
June 5th 2021
Lifileucel with Keytruda may lead to an improved overall response rate of 86% for patients with advanced melanoma who were pre-checkpoint inhibitor naïve compared with those treated with Keytruda alone.
June 4th 2021
From a cancer survivor who cleans up trash and turns it into artwork to the inaugural National Black Family Cancer Awareness week, here’s what’s happening in the cancer landscape this week.
May 26th 2021
“Summer finds many of us outdoors and during that time, it’s important to protect our skin from the dangerous rays of the sun,” writes one breast cancer survivor. Learn more about how to use sunscreen, protect your skin and avoid skin cancer.
May 20th 2021
The use of Opdivo combined with the novel therapy relatlimab resulted in a significant improvement of progression-free survival compared to treatment with Opdivo, alone, in patients with previously untreated, unresectable or metastatic melanoma.
May 17th 2021
In honor of Skin Cancer Awareness Month, CURE® compiled some recent news and updates from this field that patients, survivors and caregivers may have missed.
May 7th 2021
A melanoma survivor pens a poem about his cancer journey, losing his wife to melanoma and how he lives his life after these experiences.
May 7th 2021
Patients with melanoma treated with Keytruda had improved recurrence-free survival without an effect on their quality of life.
May 3rd 2021
When caught and treated early, skin cancer is highly curable. When allowed to progress, however, it can cause disfigurement and even death.
April 30th 2021
Which story – of hope or fear – is the best experience to relate to help another?
April 23rd 2021
In patients with resected high-risk stage 3 cutaneous melanoma, distant metastasis-free survival at 3.5 years was 65.3% in patients treated with Keytruda compared with 49.4% in those treated with placebo, which was also consistent in patients with PD-L1-positive tumors.
April 22nd 2021
Keytruda demonstrated clinical benefit for patients with recurrent and metastatic disease, according to an expert.
April 20th 2021
Active surveillance in sentinel lymph node positive melanoma could delay surgery but may result in the same risk of the cancer coming back.
April 12th 2021
Chronic immune-related adverse events from anti-PD-1 therapy occur in many patients with advanced melanoma, but shouldn’t deter them from seeking treatment that can provide long-term survival, according to an expert from Vanderbilt University Medical Center.
March 19th 2021
FDA approval of immunotherapies and BRAF/MEK inhibitors may have impacted overall survival, with a change from seven months between 2010 and 2014 to 13 months between 2015 and 2019.
March 8th 2021
As the winter months stretch on, those looking to treat Seasonal Affective Disorder (SAD) may be tempted to use indoor ultraviolet (UV) tanning devices. Not only is indoor tanning a dangerous habit, it does not successfully treat SAD.
March 1st 2021
A patient with recurrent basal cell carcinoma discusses his cancer journey, his latest challenge and how he’s now prioritized quality of life over quantity.
February 23rd 2021
Intratumoral injection—the boosting of the immune response against metastatic melanoma by the direct injection of immunotherapy into tumor masses—is a promising treatment method because it’s effective AND it seems to cause fewer toxicities for the patient than combination systemic immunotherapy.
February 16th 2021
Gina Roller’s best friend, Kerri-Lynn Larimer, adopted and lived by the motto “crazy not to” long before she was diagnosed with metastatic melanoma.
February 9th 2021
We answer this question with the help of Mohammed Kashani-Sabet, M.D., the Director, Center for Melanoma Research and Treatment; and Medical Director, Cancer Center, California Pacific Medical Center.